Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I

Arsenic trioxide (ATO) is a well-accepted chemotherapy agent in managing promyelocytic leukemia. ATO often causes severe health hazards such as hepatotoxicity, dermatosis, neurotoxicity, nephrotoxicity and cardiotoxicity. The production of reactive oxygen species, (ROS) play a significant role in AT...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Sunbin, Shan, Qiaonan, Liu, Peng, Feng, Tingting, Zhang, Xuanyu, Xiang, Penghui, Chen, Kangchen, Xie, Haiyang, Song, Penghong, Zhou, Lin, Liu, Jimin, Zheng, Shusen, Xu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775401/
https://www.ncbi.nlm.nih.gov/pubmed/29095437
http://dx.doi.org/10.1038/cddis.2017.482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775401/
https://www.ncbi.nlm.nih.gov/pubmed/29095437
http://dx.doi.org/10.1038/cddis.2017.482

Ejemplares similares